Total Payments
$10,498
2024 Payments
$1,380
Companies
40
Transactions
533
Medicare Patients
20,024
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$10,456 (99.6%)
Education$41.98 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,456 | 529 | 99.6% |
| Education | $41.98 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,727 | 104 | $0 (2024) |
| Amgen Inc. | $1,322 | 55 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,179 | 48 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $800.53 | 43 | $0 (2022) |
| Novo Nordisk Inc | $610.24 | 28 | $0 (2024) |
| ABBVIE INC. | $552.70 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $510.39 | 33 | $0 (2023) |
| Lilly USA, LLC | $452.24 | 23 | $0 (2024) |
| Esperion Therapeutics, Inc. | $433.75 | 22 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $379.40 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,380 | 70 | ABBVIE INC. ($277.03) |
| 2023 | $1,290 | 59 | GlaxoSmithKline, LLC. ($297.68) |
| 2022 | $1,606 | 74 | Novo Nordisk Inc ($300.16) |
| 2021 | $1,501 | 73 | PFIZER INC. ($239.52) |
| 2020 | $1,046 | 58 | GlaxoSmithKline, LLC. ($288.05) |
| 2019 | $1,320 | 68 | PFIZER INC. ($353.01) |
| 2018 | $1,270 | 61 | Janssen Pharmaceuticals, Inc ($273.53) |
| 2017 | $1,085 | 70 | PFIZER INC. ($437.66) |
All Payment Transactions
533 individual payment records from CMS Open Payments — Page 3 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: DIABETES | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PAIN | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Respiratory | ||||||
| 04/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $106.31 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Respiratory | ||||||
| 03/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $123.12 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Inflammation | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes | ||||||
| 02/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Inflammation | ||||||
| 01/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Diabetes | ||||||
| 01/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Inflammation | ||||||
| 11/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Inflammation | ||||||
| 11/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 4,250 | 7,891 | $874,732 | $384,526 |
| 2022 | 56 | 4,827 | 9,112 | $961,814 | $442,365 |
| 2021 | 55 | 5,369 | 10,024 | $1.0M | $481,638 |
| 2020 | 58 | 5,578 | 10,239 | $1.0M | $466,848 |
Total Patients
20,024
Total Services
37,266
Medicare Billing
$1.8M
Procedure Codes
215
All Medicare Procedures & Services
215 procedure records from CMS Medicare Utilization — Page 2 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 94 | 120 | $4,800 | $1,142 | 23.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,890 | $993.06 | 52.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 51 | 70 | $2,450 | $935.20 | 38.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 23 | $2,070 | $917.84 | 44.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 29 | 32 | $3,200 | $909.58 | 28.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 11 | 11 | $1,430 | $718.19 | 50.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 28 | 32 | $1,430 | $521.64 | 36.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 46 | 48 | $2,880 | $516.12 | 17.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 79 | 90 | $1,350 | $509.40 | 37.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 80 | 91 | $1,365 | $462.28 | 33.9% |
| 83550 | Iron binding capacity | Office | 2023 | 37 | 51 | $2,040 | $437.07 | 21.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 99 | 128 | $1,280 | $436.48 | 34.1% |
| 86141 | Measurement c-reactive protein for detection of infection or inflammation, high sensitivity | Office | 2023 | 31 | 34 | $1,360 | $431.46 | 31.7% |
| 84550 | Uric acid level, blood | Office | 2023 | 60 | 83 | $1,245 | $367.69 | 29.5% |
| G0451 | Development testing, with interpretation and report, per standardized instrument form | Office | 2023 | 44 | 44 | $1,100 | $344.40 | 31.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 17 | 17 | $714.00 | $321.64 | 45.0% |
| 83540 | Iron level | Office | 2023 | 37 | 50 | $1,500 | $317.00 | 21.1% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 31 | 35 | $525.00 | $146.30 | 27.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 16 | $128.00 | $125.44 | 98.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 14 | 14 | $420.00 | $78.46 | 18.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 33 | 76 | $1,140 | $71.63 | 6.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 299 | 889 | $177,700 | $80,034 | 45.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 284 | 1,212 | $157,560 | $71,152 | 45.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 330 | 406 | $111,650 | $64,070 | 57.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 298 | 555 | $83,275 | $46,240 | 55.5% |
About Dr. Nicolas Marsheh, M.D
Dr. Nicolas Marsheh, M.D is a Internal Medicine healthcare provider based in Sterling Heights, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962423657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicolas Marsheh, M.D has received a total of $10,498 in payments from pharmaceutical and medical device companies, with $1,380 received in 2024. These payments were reported across 533 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($10,456).
As a Medicare-enrolled provider, Marsheh has provided services to 20,024 Medicare beneficiaries, totaling 37,266 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 215 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Sterling Heights, MI
- Active Since 07/21/2006
- Last Updated 04/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962423657
Products in Payments
- XARELTO (Drug) $705.45
- TRELEGY ELLIPTA (Drug) $700.12
- ELIQUIS (Drug) $649.19
- Otezla (Drug) $505.28
- ENTRESTO (Drug) $493.23
- VRAYLAR (Drug) $440.22
- Repatha (Biological) $375.14
- CHANTIX (Drug) $337.27
- LYRICA (Drug) $331.60
- Ozempic (Drug) $322.97
- NEXLETOL (Drug) $313.70
- Aimovig (Biological) $276.56
- Vascepa (Drug) $232.60
- Rybelsus (Drug) $217.36
- COLOGUARD (Device) $203.23
- Cologuard Collection Kit (Device) $199.74
- MOUNJARO (Drug) $184.38
- ANORO ELLIPTA (Drug) $161.12
- AJOVY (Biological) $152.63
- TOUJEO (Drug) $141.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sterling Heights
Dr. Syed Ali Muttaqi Husain, M.d, M.D
Internal Medicine — Payments: $54,045
Internal Medicine $54,045
Sandeep Garg, Md, MD
Internal Medicine — Payments: $37,573
Internal Medicine $37,573
Dr. Sami Asmar, M.d, M.D
Internal Medicine — Payments: $13,662
Internal Medicine $13,662
Dr. Zbigniew Purzycki, M.d, M.D
Internal Medicine — Payments: $12,572
Internal Medicine $12,572
Dr. Victor Al-Matchy, M.d, M.D
Internal Medicine — Payments: $12,259
Internal Medicine $12,259
Mazen Alsaqa, M.d, M.D
Internal Medicine — Payments: $9,495
Internal Medicine $9,495